Hebei Changshan Biochemical Pharmaceutical Company Description

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally.

It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection.

The company was founded in 2000 and is based in Shijiazhuang, China.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Country	China
Founded	2000
Industry	Biotechnology
Sector	Healthcare
Employees	1,410
CEO	Hao Cai

Contact Details

Address: Zhengding High-tech Industrial Development Zone Shijiazhuang, Hebei Province 050800 China
Phone	86 311 8919 0181
Website	hbcsbio.com

Stock Details

Ticker Symbol	300255
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000016C2
SIC Code	2834

Key Executives

Name	Position
Hao Cai	General Manager
Xiaohua Yue	Deputy GM and Chief Financial Officer
Yunxia Sun	Deputy GM and Non-Independent Director
Zhihua Li	Deputy General Manager
Qing Zhang	Deputy General Manager